Warner Chilcott UK Limited

1 The Heights, Brooklands, Weybridge, KT12 0NY

Telephone: +44 (0)1932 82 9600
Fax: +44 (0)1932 82 1644
WWW: http://www.wcrx.com
Medical Information Direct Line: +44 (0)800 0328 701

Medical Information e-mail: medcomukir@wcrx.com
Medical Information Fax: +44 (0)1932 824 775

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 07/10/2011

PIL	Intrinsa 300 micrograms/24 hours transdermal patch

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/10/2011 and displayed until Current

Reasons for adding or updating:
Change to side-effects Change to Marketing Authorisation Holder Change to date of revision Change to warnings or special precautions for use Change to storage instructions Company name change or merger Change to name of manufacturer Change to MA holder contact details

Updated on 08/09/2008 and displayed until 07/10/2011

Reasons for adding or updating:
Change to side-effects

Updated on 27/03/2007 and displayed until 08/09/2008

Reasons for adding or updating:
Improved Electronic Presentation

Updated on 26/03/2007 and displayed until 27/03/2007

Reasons for adding or updating:
New PIL for new product

Document Links

View all medicines
from this company

View Document

Active Ingredients/Generics

testosterone

Versions

	07/10/2011 to Current
	08/09/2008 to 07/10/2011
	27/03/2007 to 08/09/2008
	26/03/2007 to 27/03/2007

Return to the top of the page